Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL – Get Free Report) was the target of a large decrease in short interest during the month of February. As of February 29th, there was short interest totalling 11,000 shares, a decrease of 9.8% from the February 14th total of 12,200 shares. Currently, 0.3% of the shares of the company are sold short. Based on an average daily trading volume, of 7,400 shares, the short-interest ratio is currently 1.5 days.
Institutional Trading of Cryo-Cell International
A number of institutional investors and hedge funds have recently made changes to their positions in CCEL. Vanguard Group Inc. increased its position in Cryo-Cell International by 8.7% during the 4th quarter. Vanguard Group Inc. now owns 91,139 shares of the company’s stock worth $524,000 after purchasing an additional 7,256 shares in the last quarter. Northern Trust Corp acquired a new position in Cryo-Cell International during the 4th quarter worth approximately $151,000. Finally, Cerity Partners LLC acquired a new position in Cryo-Cell International during the 4th quarter worth approximately $83,000. Institutional investors own 10.01% of the company’s stock.
Cryo-Cell International Stock Up 2.5 %
NYSEAMERICAN CCEL opened at $5.79 on Tuesday. The company has a market cap of $48.00 million, a P/E ratio of -5.08 and a beta of 0.41. Cryo-Cell International has a 12-month low of $2.69 and a 12-month high of $7.25. The firm has a 50-day simple moving average of $5.69.
About Cryo-Cell International
Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases.
See Also
- Five stocks we like better than Cryo-Cell International
- Roth IRA Calculator: Calculate Your Potential Returns
- Walmart: Here’s Your Chance to Get in Cheaper in 2024
- How to Invest in Blue Chip Stocks
- Insider Selling of Amazon Spikes in Q1, but it’s Not Time to Sell
- 3 Small Caps With Big Return Potential
- 2 Deep Value, High Yield Stocks With a Double-Digit Upside
Receive News & Ratings for Cryo-Cell International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cryo-Cell International and related companies with MarketBeat.com's FREE daily email newsletter.